Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 12, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2021. Go to the latest filing (Q3 2026)

10.9B USDQ3 2021
Total value of stock positions
10.9B USD
Positions
56
Share of the ten largest
67.8%

The ten largest positions Q3 2021

  1. Liberty Global PLC 14.6%unchanged
  2. Intel 9.7%▼ −9.2%
  3. Viasat Inc 8.3%unchanged
  4. Qorvo Inc 7.8%▼ −4.7%
  5. Alphabet Inc. (Class C) 7.1%unchanged
  6. Meta Platforms 4.8%unchanged
  7. Micron Technology 4.7%unchanged
  8. Liberty Media Corp Del 4.0%▲ +40.1%
  9. eBay Inc. 3.8%▼ −59.8%
  10. Veritiv Corp 2.9%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q3 2021

Positions Q3 2021 per 13F filing, 9 of 9
Symbol Weight in previous quarter Shares in previous quarter Value in previous quarter Change
Translate Bio Inc 4.0% 18,044,239 493.5M USD sold out
Reinvent Technology Partners 0.5% 6,000,000 59.3M USD sold out
Ajax I 0.3% 4,223,918 42.1M USD sold out
Reinvent Technology Partners 0.3% 3,500,000 34.9M USD sold out
Reinvent Technology Partners < 0.1% 1,000,000 9.9M USD sold out
The Beauty Health Company < 0.1% 898,981 5.8M USD sold out
Ajax I < 0.1% 1,250,000 2.3M USD sold out
Reinvent Technology Partners < 0.1% 875,000 1.7M USD sold out
Reinvent Technology Partners < 0.1% 200,000 362.0K USD sold out
Plus 1 position in convertible bonds and bonds worth 27.6M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 27.6M USD

Breakdown by sector

  • Technology 14.4%
  • Communication Services 12.0%
  • Consumer Discretionary 3.8%
  • Financials 2.1%
  • Materials 1.5%
  • Industrials 0.9%
  • Utilities 0.6%
  • not in our coverage 64.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close